Key Data

Bayer Group Key Data

        
 2nd Quarter 20142nd Quarter 2015Change1st Half
2014
1st Half
2015
Change Full Year
2014
 € million€ million%€ million€ million%€ million
Sales10,22812,090+18.220,58023,969+16.5 41,339
Change (adjusted for currency and portfolio effects)  +3.7  +3.2 +7.7
        
Change in sales       
Volume+6.0%+4.9% +7.4%+3.8%  +7.1%
Price+0.8%-1.2% +0.4%-0.6%  +0.6%
Currency-5.5%+9.0% -5.7%+8.2% -2.8%
Portfolio+0.1%+5.5% +0.2%+5.1%  +0.7%
        
EBIT11,4351,833+27.73,5003,777+7.9 5,395
Special items(48)(255)  (41)(499)  (438)
EBIT before special items21,4832,088+40.83,5414,276+20.8 5,833
        
EBIT margin before special items314.5%17.3% 17.2%17.8% 14.1%
        
EBITDA42,1352,648+24.04,8455,393+11.3 8,315
Special items (41)(251)  (34)(447)  (370)
EBITDA before special items22,1762,899+33.24,8795,840+19.7 8,685
        
EBITDA margin before special items321.3%24.0% 23.7%24.4%  21.0%
        
Financial result(173)(287)-65.9(332)(561)-69.0(981)
        
Net income (from continuing and discontinued operations)9531,152+20.92,3762,455+3.33,426
Earnings per share (from continuing and discontinued operations)(€)51.151.39+20.92.872.97+3.54.14
        
Core earnings per share (from continuing operations) (€)61.481.98+33.83.404.02+18.2 5.89
        
Gross cash flow71,6652,173+30.53,6834,184+13.6 6,707
        
Net cash flow81,6011,959+22.41,7642,683+52.15,810
        
Cash outflows for capital expenditures 529601+13.6886946+6.82,371
        
Research and development expenses8411,036+23.21,6531,982+19.9 3,537
        
Depreciation, amortization and impairments700815+16.41,3451,616+20.1 2,920
        
Number of employees at end of period9112,556117,798+4.7112,556117,798+4.7 117,371
Personnel expenses (including pension expenses)2,3662,750+16.24,7495,630+18.6 9,693
2014 figures restated
In some cases, the sum of the figures given in this report may not precisely equal the stated totals and percentages may not be exact due to rounding.
1
EBIT = earnings before financial result and taxes
2 EBIT before special items and EBITDA before special items are not defined in the International Financial Reporting Standards and should therefore be regarded only as supplementary information. EBITDA before special items is a meaningful indicator of operating performance since it is not affected by depreciation, amortization, impairments or special items. By reporting this indicator, the company aims to give readers a clear picture of the results of operations and ensure comparability of data over time. See also Chapter 6 “Calculation of EBIT(DA) Before Special Items.”
3 The EBIT(DA) margin before special items is calculated by dividing EBIT(DA) before special items by sales.
4 EBITDA = EBIT plus amortization and impairment losses on intangible assets and depreciation and impairment losses on property, plant and equipment, minus impairment loss reversals
5
Earnings per share as defined in IAS 33 = net income divided by the average number of shares
6 Core earnings per share are not defined in the International Financial Reporting Standards. By reporting this indicator, the company aims to give readers a clear picture of the results of operations and ensure comparability of data over time. The calculation of core earnings per share is explained in Chapter 7 “Core Earnings Per Share.”
7
Gross cash flow = income after income taxes, plus income taxes, plus financial result, minus income taxes paid or accrued, plus depreciation, amortization and impairment losses, minus impairment loss reversals, plus/ minus changes in pension provisions, minus gains / plus losses on retirements of noncurrent assets, minus gains from the remeasurement of already held assets in step acquisitions. The change in pension provisions includes the elimination of non-cash components of EBIT. It also contains benefit payments during the year. For details see Chapter 8 “Financial Position of the Bayer Group.”
8
Net cash flow = cash flow from operating activities according to IAS 7
9 Full-time equivalents
Last updated: July 29, 2015  Copyright © Bayer AG
http://www.quarterly-report-2015-q2.bayer.com